Trial NCT06205290

View at ClinicalTrials.gov 
Org. Study IDs: CA082-1170

Last trial update was posted on 2024-04-02

MeSH Interventions

Bendamustine Hydrochloride Cyclophosphamide Fludarabine Idelalisib Rituximab

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid Lymphoma

Other Conditions


Stopping Reasons

Business objectives have changed.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID